Correction: A 32 kb Critical Region Excluding Y402H in CFH Mediates Risk for Age-Related Macular Degeneration.
[This corrects the article DOI: 10.1371/journal.pone.0025598.].
Main Authors: | Theru A Sivakumaran, Robert P Igo, Jeffrey M Kidd, Andy Itsara, Laura J Kopplin, Wei Chen, Stephanie A Hagstrom, Neal S Peachey, Peter J Francis, Michael L Klein, Emily Y Chew, Vedam L Ramprasad, Wan-Ting Tay, Paul Mitchell, Mark Seielstad, Dwight E Stambolian, Albert O Edwards, Kristine E Lee, Dmitry V Leontiev, Gyungah Jun, Yang Wang, Liping Tian, Feiyou Qiu, Alice K Henning, Thomas LaFramboise, Parveen Sen, Manoharan Aarthi, Ronnie George, Rajiv Raman, Manmath Kumar Das, Lingam Vijaya, Govindasamy Kumaramanickavel, Tien Y Wong, Anand Swaroop, Goncalo R Abecasis, Ronald Klein, Barbara E K Klein, Deborah A Nickerson, Evan E Eichler, Sudha K Iyengar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0209943 |
Similar Items
-
A 32 kb critical region excluding Y402H in CFH mediates risk for age-related macular degeneration.
by: Theru A Sivakumaran, et al.
Published: (2011-01-01) -
CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD.
by: Kristinn P Magnusson, et al.
Published: (2006-01-01) -
CFH Y402H Confers Similar Risk of Soft Drusen and Both Forms of Advanced AMD.
Published: (2005-11-01) -
Association between CFH Y402H polymorphism and age related macular degeneration in North Indian cohort.
by: Neel Kamal Sharma, et al.
Published: (2013-01-01) -
CFH Y402H polymorphism and response to intravitreal Ranibizumab in brazilian patients with neovascular age-related macular degeneration
by: Carlos Eduardo Veloso, et al.